GAITHERSBURG, Md. (MedPage Today) — An FDA advisory panel was divided over whether to recommend the approval of the investigational weight-loss drug phentermine/topiramate (Qnexa), but the Nay votes prevailed 10-6. (Source: MedPage Today Public Health)
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and re ceive $5 free advertising.
PHILADELPHIA – The American Home Products National Settlement as amended and interpreted by the supervising judge discriminates against obese persons and runs counter to accepted medical practice, an unsuccessful claimant argues to the Third Circuit U.S. Court of Appeals (In Re: Diet Drugs [Phentermine/Fenfluramine/Dexfenfluramine] Products Liability L itigation, MDL Do cket No. 1203, Sheila Brown, et al. v. American Home Products Corp., No. (more…)
PHILADELPHIA – Wyeth Inc. on Aug. 3 moved for summary judgment of a case asserting primary pulmonary hypertension (PPH), saying a widow’s claim that her husband u sed diet drugs prescribed for her constitutes an illegal act from which she may not profit (In Re: Diet Drugs [Phentermine/Fenfluramine/Dexfenfluramine] Products Liability Litigation, MDL Docket No. 1203, Ragena J. Mize Crowe, et al. v. American Home Products Corporation, et al., No. (more…)
PHILADELPHIA – Wyeth Inc. on June 18 moved to dismiss and for fees and costs, saying a plaintiff who alleges that his wife died of primary pulmonary hypertension (PPH) caused by the company’s diet drugs has no proof of their use (In Re: Diet Drugs [ Phentermine/Fenfluramine/Dexfenfluramine] Products Liability Litigation, MDL Docket No. 1203, Sheila Brown, et al. v. American Home Products Corp., No. 99-20593, Roscoe A. Dellinger v. Wyeth, No. (more…)
Antiobesity effects of the β-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats
International Journal of Obesity advance online publication, June 17, 2008. doi:10.1038/ijo.2008.91
Au thors: J D Roth, J L Trevaskis, J Wilson, C Lei, J Athanacio, C Mack, N C Kesty, T Coffey, C Weyer
& D G Parkes (Source: International Journal of Obesity)
Internet pharmacy sites selling weight loss medications around the world are common, and often illegal according to many national regulatory bodies such as the DEA. Where a buyer resides dictates whether obesity medications such as Phentermine, the USA's most popular prescription diet pill, can be purchased legally online and from whom; e.g. unlicensed / non-US based pharmacies are prohibited in America (FDA/DEA). Up to now finding a web (more…)
PHILADELPHIA – Calling it the “largest private-party settlement in the history of American litigation,” attorneys who administered the multidistrict litigation (MDL) over America n Home Products’ diet drugs and negotiated the settlement valued at more than $5 billion on July 16 applied for a $403 million final award of common benefit fees (In Re: Diet Drugs [Phentermine/Fenfluramine/Dexfenfluramine] Products Liability Litigation, MDL Docket No. (more…)
Authors: Makaryus JN, Makaryus AN
The obesity epidemic currently plaguing the United States has spurred the development of a vast number of drugs to assist in the battle against obesity and its associated complications. The need to loose weight often ca uses patients to loose sight of or even ignore the serious side effects of some of the most widely used weight-loss medications. Here we present the case of ventricular tachycardia/fibrillation (more…)
Patients taking a novel diet drug that combines the stimulant phentermine with the anticonvulsant topiramate lost an average of 37 pounds over a year with significant improvement in a number of cardiovascular ri sk factors, according to an announcement from Vivus, the developer of the drug. (Source: MedPage Today Pediatrics)
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising. (more…)
PHILADELPHIA – A prominent diet drug plaintiff firm has filed objections to a common benefit fee application by a former assoc iate, saying any such fee belongs to the firm (In Re: Diet Drugs [Phentermine/Fenfluramine/Dexfenfluramine] Products Liability Litigation, MDL Docket No. 1203, Sheila Brown, et al. v. American Home Products Corp., No. 99-20593, E.D. Pa.).
Full story on lexis.com (Source: LexisNexis® Mealey’s™ Fen-Phen/Redux (more…)